Three thyroid cancer drugs approved for NHS in England

Anne Li                                                                                      March 11th, 2018

Three thyroid cancer treatments have been approved for routine use on the NHS in England. The recommendation by the National Institute for Health and Care Excellence (NICE) will move cabozantinib (Cometriq) and sorafenib (Nexavar) from the Cancer Drugs Fund. Lenvatinib (Lenvima) was the third drug to be approved, after previously being available only on compassionate grounds.


See original article at:



登錄 X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.